PDE inhibitor

Related by string. PDE inhibitors * PDEs . PDES . Pde : PDE #D# . Beaconsfield Pde . Somme Pde . phosphodiesterase PDE . PDE 5i . PDE 5i medications . Marine Pde / Inhibitor . Inhibitors . inhibitors : proton pump inhibitors . proton pump inhibitors PPIs . small molecule inhibitor . proton pump inhibitor PPI . ACE inhibitors . Proton Pump Inhibitors PPIs . angiotensin converting enzyme inhibitors * *

Related by context. Frequent words. (Click for all words.) 60 Phase Ib clinical 59 anticancer compound 59 celgosivir 59 registrational trial 59 phase IIb 58 Phase Ib 58 outlicensing 58 PROMACTA 58 eniluracil 58 isavuconazole 57 IMC A# 57 Phase IIb clinical 57 Virulizin R 56 methylnaltrexone 56 Phase 2a clinical 56 Phase 2a trial 56 registrational 56 confirmatory Phase III 56 cangrelor 56 daclizumab 56 Lu AA# 56 OXi# 56 atacicept 55 Phase 1b clinical 55 double blinded placebo 55 tanespimycin 55 Phase 2b trial 55 Cloretazine R VNP#M 55 Phase III clinical 55 phase 2a 55 deforolimus 54 Phase 1b trial 54 Phase IIa trial 54 phase IIa 54 ponatinib 54 dose titration 54 Phase 2b study 53 Zerenex 53 IND enabling 53 squalamine 53 nab paclitaxel 53 RRMS patients 53 Phase IIa clinical trials 53 IMGN# 53 Phase 1b 53 Phase 2b 53 Phase 2a 53 Phase 2b clinical 53 Phase IIa 52 confirmatory Phase 3 52 IND submission 52 X Excite 52 Phase 1a 52 preclinical toxicology 52 Phase IIb 52 Nasulin 52 Phase IIa clinical 52 Phase IIb trial 51 BLA submission 51 Phase III trials 51 Cethrin 51 Diamyd ® 51 Phase Ia 51 romidepsin 51 BNC# 50 Phase III clinical trials 50 NKTR 50 multiple ascending dose 50 pivotal Phase III 50 MIRCERA 50 placebo controlled randomized 50 Phase III 50 Menerba 49 dose escalation 49 pharmacokinetic studies 49 ALKS 49 mg kg dose 49 darinaparsin 49 unblinding 49 pafuramidine 49 dose escalation trial 48 pivotal Phase 48 virologic failure 48 RiVax ™ 48 AVN# [001] 48 downregulation 48 NEBIDO 47 PA# [002] 47 bone metastasis 47 FavId 47 randomized Phase 47 empiric 46 Phase III pivotal 46 Phase II 46 AZX# 46 relapsed refractory 46 single ascending dose 45 heavily pretreated 45 randomized Phase III 44 allogeneic stem cell 43 Phase

Back to home page